NCT01351298 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Nasal Prep for Nasendoscopy in Children


Sponsors: Children's & Women's Health Centre of British Columbia	Phases: Phase IV
Indications	Acronym:
Flexible Nasendoscopy
Age Groups: Child	Gender: Both
Names: Drug: 0.05% xylometazoline hydrochloride with 1% lidocaine hydrochloride Drug: 0.05% xylometazoline hydrochloride Drug: Isotonic normal saline	Enrollment: 70

Additional information about NCT01351298.